Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Basilea PharmaceuticaRetrophinAchillion PharmaceuticalsAkebia TherapeuticsViking Therapeutics
SymbolOTCMKTS:BPMUFNASDAQ:RTRXNASDAQ:ACHNNASDAQ:AKBANASDAQ:VKTX
Price Information
Current Price$42.28$11.24$6.09$4.16$6.54
52 Week RangeBuyBuyHoldBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuyBuy
Consensus Price TargetN/A$29.71$4.40$13.50$19.79
% Upside from Price TargetN/A164.36% upside-27.75% downside224.52% upside202.77% upside
Trade Information
Market Cap$502.05 million$490.54 million$866.10 million$511.11 million$483.81 million
Beta1.080.81.571.432.31
Average Volume3503,8405,109,738783,5351,533,993
Sales & Book Value
Annual Revenue$103.15 million$164.25 million$15 million$207.74 millionN/A
Price / Sales4.872.9456.712.38N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value($3.55) per share$7.72 per share$1.92 per share$5.44 per share$4.17 per share
Price / Book-11.911.463.170.76N/A
Profitability
Net Income$-19,670,000.00$-102,680,000.00$-70,270,000.00$-143,590,000.00$-22,060,000.00
EPSN/A($2.54)($0.51)($2.44)($0.40)
Trailing P/E Ratio0.00N/AN/AN/AN/A
Forward P/E Ratio4,228.00N/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-83.94%N/A-75.64%N/A
Return on Equity (ROE)N/A-47.21%-27.60%-36.92%-8.27%
Return on Assets (ROA)N/A-20.67%-26.30%-22.10%-8.12%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.72%N/A0.06%N/A
Current RatioN/A5.05%14.64%1.70%52.19%
Quick RatioN/A4.99%14.64%1.05%52.19%
Ownership Information
Institutional Ownership PercentageN/AN/A78.57%71.86%62.58%
Insider Ownership PercentageN/A4.32%4.58%2.66%3.49%
Miscellaneous
Employees2272145632415
Shares Outstanding11.87 million42.95 million139.69 million118.86 million72.21 million
Next Earnings DateN/A10/30/2019 (Confirmed)11/6/2019 (Estimated)11/14/2019 (Estimated)11/6/2019 (Estimated)
OptionableNot OptionableOptionableOptionableOptionableOptionable
 Basilea PharmaceuticaRetrophinAchillion PharmaceuticalsAkebia TherapeuticsViking Therapeutics

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel